Suppr超能文献

联合手术患者安全系统和世界卫生组织清单在外科手术中的临床疗效:一项非随机临床试验。

Clinical Efficacy of Combined Surgical Patient Safety System and the World Health Organization's Checklists in Surgery: A Nonrandomized Clinical Trial.

机构信息

Department of Anesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.

Department of Clinical Medicine, Faculty of Medicine, University of Bergen, Bergen, Norway.

出版信息

JAMA Surg. 2020 Jul 1;155(7):562-570. doi: 10.1001/jamasurg.2020.0989.

Abstract

IMPORTANCE

Checklists have been shown to improve patient outcomes in surgery. The intraoperatively used World Health Organization surgical safety checklist (WHO SSC) is now mandatory in many countries. The only evidenced checklist to address preoperative and postoperative care is the Surgical Patient Safety System (SURPASS), which has been found to be effective in improving patient outcomes. To date, the WHO SSC and SURPASS have not been studied jointly within the perioperative pathway.

OBJECTIVE

To investigate the association of combined use of the preoperative and postoperative SURPASS and the WHO SSC in perioperative care with morbidity, mortality, and length of hospital stay.

DESIGN, SETTING, AND PARTICIPANTS: In a stepped-wedge cluster nonrandomized clinical trial, the preoperative and postoperative SURPASS checklists were implemented in 3 surgical departments (neurosurgery, orthopedics, and gynecology) in a Norwegian tertiary hospital, serving as their own controls. Three surgical units offered additional parallel controls. Data were collected from November 1, 2012, to March 31, 2015, including surgical procedures without any restrictions to patient age. Data were analyzed from September 25, 2018, to March 29, 2019.

INTERVENTIONS

Individualized preoperative and postoperative SURPASS checklists were added to the intraoperative WHO SSC.

MAIN OUTCOMES AND MEASURES

Primary outcomes were in-hospital complications, emergency reoperations, unplanned 30-day readmissions, and 30-day mortality. The secondary outcome was length of hospital stay (LOS).

RESULTS

In total, 9009 procedures (5601 women [62.2%]; mean [SD] patient age, 51.7 [22.2] years) were included, with 5117 intervention procedures (mean [SD] patient age, 51.8 [22.4] years; 2913 women [56.9%]) compared with 3892 controls (mean [SD] patient age, 51.5 [21.8] years; 2688 women [69.1%]). Parallel control units included 9678 procedures (mean [SD] patient age, 57.4 [22.2] years; 4124 women [42.6%]). In addition to the WHO SSC, adjusted analyses showed that adherence to the preoperative SURPASS checklists was associated with reduced complications (odds ratio [OR], 0.70; 95% CI, 0.50-0.98; P = .04) and reoperations (OR, 0.42; 95% CI, 0.23-0.76; P = .004). Adherence to the postoperative SURPASS checklists was associated with decreased readmissions (OR, 0.32; 95% CI, 0.16-0.64; P = .001). No changes were observed in mortality or LOS. In parallel control units, complications increased (OR, 1.09; 95% CI, 1.01-1.17; P = .04), whereas reoperations, readmissions, and mortality remained unchanged.

CONCLUSIONS AND RELEVANCE

In this nonrandomized clinical trial, adding preoperative and postoperative SURPASS to the WHO SSC was associated with a reduction in the rate of complications, reoperations, and readmissions.

TRIAL REGISTRATION

ClinicalTrials.gov Identifier: NCT01872195.

摘要

重要性

清单已被证明可以改善手术患者的结局。目前,许多国家都强制性使用术中世界卫生组织手术安全检查表(WHO SSC)。唯一被证明可以解决术前和术后护理问题的检查表是外科患者安全系统(SURPASS),该检查表已被证明可以有效改善患者结局。迄今为止,WHO SSC 和 SURPASS 尚未在围手术期路径中联合研究。

目的

调查术前和术后 SURPASS 以及 WHO SSC 在围手术期护理中的联合使用与发病率、死亡率和住院时间的关系。

设计、地点和参与者:在一项逐步楔形非随机临床试验中,术前和术后 SURPASS 检查表在挪威一家三级医院的 3 个外科部门(神经外科、骨科和妇科)实施,这些部门作为自身对照。另外 3 个外科单位提供了额外的平行对照。数据采集于 2012 年 11 月 1 日至 2015 年 3 月 31 日,包括对无年龄限制的手术。数据分析于 2018 年 9 月 25 日至 2019 年 3 月 29 日进行。

干预措施

在术中 WHO SSC 中添加个性化的术前和术后 SURPASS 检查表。

主要结果和测量指标

主要结局为院内并发症、急诊再次手术、计划外 30 天再入院和 30 天死亡率。次要结局为住院时间(LOS)。

结果

共纳入 9009 例手术(5601 例女性[62.2%];平均[SD]患者年龄为 51.7[22.2]岁),其中 5117 例为干预性手术(平均[SD]患者年龄为 51.8[22.4]岁;2913 例女性[56.9%]),与 3892 例对照组(平均[SD]患者年龄为 51.5[21.8]岁;2688 例女性[69.1%])相比。平行对照组纳入 9678 例手术(平均[SD]患者年龄为 57.4[22.2]岁;4124 例女性[42.6%])。除了 WHO SSC 之外,调整分析显示,术前 SURPASS 检查表的依从性与降低并发症(比值比[OR],0.70;95%置信区间[CI],0.50-0.98;P = 0.04)和再次手术(OR,0.42;95% CI,0.23-0.76;P = 0.004)相关。术后 SURPASS 检查表的依从性与降低再入院率(OR,0.32;95% CI,0.16-0.64;P = 0.001)相关。死亡率或 LOS 没有变化。在平行对照组中,并发症发生率增加(OR,1.09;95% CI,1.01-1.17;P = 0.04),而再次手术、再入院和死亡率保持不变。

结论和相关性

在这项非随机临床试验中,将术前和术后 SURPASS 添加到 WHO SSC 中与并发症、再次手术和再入院率的降低相关。

试验注册

ClinicalTrials.gov 标识符:NCT01872195。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72e4/7221852/3f873eaf2828/jamasurg-155-562-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验